Walpar Nutritions P/B Ratio
Current P/B Ratio
2.58
Moderate Valuation
High - Premium to book value, growth expectations or asset-light model
Walpar Nutritions P/B ratio. Walpar Nutritions (WALPAR) P/B ratio is 2.58 (Moderate), book value per share ₹21.11 vs Healthcare average P/B of 0.01 — High - Premium to book value, growth expectations or asset-light model. Analyse Walpar Nutritions ownership pattern to track promoter, FII and institutional holdings.
Current Valuation Metrics
P/B Ratio
2.58
Current Price
₹
Book Value/Share
₹21.11
Exchange
None
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹19 Cr
Share Capital
₹9 Cr
Reserves & Surplus
₹7 Cr
Outstanding Shares
9,000,000
Book Value per Share
₹21.11
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
0.01
Sector Median
0.61
Sector Rank
#11 of 50
Sector Percentile
22.0%
WALPAR P/B Ratio — Valuation Insights & Book Value Analysis
Walpar Nutritions price-to-book ratio interpretation, valuation status and historical context — current P/B 2.58 (Moderate). For live price, earnings yield and the full fundamental profile, see Walpar Nutritions share price chart.
- Trading at premium to sector average PB of 0.01
WALPAR vs Healthcare Peers — P/B Ratio Comparison
Walpar Nutritions P/B 2.58 vs Healthcare average 0.01, median 0.61 — range -6.55–1.13.
Sector Average
0.01
Sector Median
0.61
Lowest P/B
-6.55
Highest P/B
1.13
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.19 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |